Ascentage Pharma Group International (NASDAQ:AAPG - Get Free Report) shot up 5.1% during trading on Tuesday . The company traded as high as $23.30 and last traded at $23.07. 7,171 shares traded hands during mid-day trading, a decline of 91% from the average session volume of 82,682 shares. The stock had previously closed at $21.95.
Analyst Ratings Changes
Separately, JPMorgan Chase & Co. assumed coverage on Ascentage Pharma Group International in a research report on Thursday, March 27th. They issued an "overweight" rating for the company.
View Our Latest Stock Report on AAPG
Ascentage Pharma Group International Stock Down 9.2 %
Ascentage Pharma Group International Company Profile
(
Get Free Report)
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Featured Articles
Before you consider Ascentage Pharma Group International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ascentage Pharma Group International wasn't on the list.
While Ascentage Pharma Group International currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
